Arbutus Biopharma Corp (NASDAQ:ABUS)

5.75
Delayed Data
As of 11:13am ET
 -0.05 / -0.86%
Today’s Change
3.20
Today|||52-Week Range
8.25
+13.86%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close5.80
Today’s open5.75
Day’s range5.65 - 5.80
Volume29,185
Average volume (3 months)165,715
Market cap$366.9M
Data as of 11:13am ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+78.45%
Earnings growth (this year)-0.48%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+617.64%
P/E ratioNM
Price/Sales25.83
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+0.10+2.63%
DRRXDURECT Corp+0.21+11.17%
CPRXCatalyst Pharmaceuti...-0.08-2.35%
PETXAratana Therapeutics...+0.03+0.55%
Data as of 11:27am ET, 05/25/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$10.7M
Annual profit (last year)-$84.4M
Net profit margin-788.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer
Koert VandenEnden
Corporate headquarters
Burnaby, British Columbia

Forecasts